Page last updated: 2024-11-05

thalidomide and Cardiac Rupture, Traumatic

thalidomide has been researched along with Cardiac Rupture, Traumatic in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loh, HK1
Sahoo, KC1
Kishore, K1
Ray, R1
Nag, TC1
Kumari, S1
Arya, DS1

Other Studies

1 other study available for thalidomide and Cardiac Rupture, Traumatic

ArticleYear
Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 100, Issue:4

    Topics: Administration, Oral; Animals; Blood Pressure; Dose-Response Relationship, Drug; Endocardium; Heart;

2007